Timing of High Dose Melphalan (HDM) and Outcomes for Autologous Stem Cell Transplantation (ASCT) in Patients With Multiple Myeloma (MM)
A. Mahindra, B. Bolwell, L. Rybicki, R. Sobecks, B. Pohlman, S. Andresen, M. Earl, R. Dean, E. Copelan, M. KalaycioVolume:
15
Year:
2009
Language:
english
Pages:
43
DOI:
10.1016/j.bbmt.2008.12.126
File:
PDF, 75 KB
english, 2009